![]() |
CAS No. : | 570406-98-3 |
Cat. No. : | A645681 | |
Formula : | C29H34Cl2N6O3S2 | |
Purity : | 98% | |
M.W : | 649.65 g/mol | |
Synonyms : |
1. Avatrombopag |
|
MDL No. : | MFCD18633249 | |
Storage : | Sealed in dry, store in freezer, under -20°C | |
InChI Key : | N/A | |
Pubchem ID : | 9852519 | |
Linear Structure Formula : | - | |
Boiling Point : | - |
Safety of [ 570406-98-3 ] | |||
---|---|---|---|
Signal Word : | Warning | Class : | N/A |
Precautionary Statements : | P280-P305+P351+P338 | UN# : | N/A |
Hazard Statements : | H317-H319 | Packing Group : | N/A |
GHS Pictogram : |
![]() |
Biological Activity of [ 570406-98-3 ] | |
---|---|
Description : |
Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist with an EC50 of 3.3 nM. It mimics the biological activities of TPO, stimulating platelet production by activating the intracellular signaling system and promoting the generation of platelets and megakaryocytes from hematopoietic precursor cells. Avatrombopag is metabolized by cytochrome P450 (CYP) 2C9 and CYP3A enzymes [1][2][3].
Show More |